AN OVERVIEW OF INCRETIN-BASED THERAPIES: PHARMACOLOGY AND FUTURE PERSPECTIVES

Beyond Benefits: The Unseen Risks of GLP-1 Receptor Agonists in Recent Trials

The Role of incretin-based therapies in maintaining glucose homeostasis and management of diabetes mellitus

Retrospective Study Reveals Association between Type 2 Diabetes Mellitus and Certain Types of Cancer

Glucose-Lowering Drugs and Fracture Risk among Diabetics: Review Article

Angiogenesis Versus Antiangiogenesis in Colorectal Cancer Patients with and Without Liver Metastases

ADDITION OF SITAGLIPTIN TO REPAGLINIDE IMPROVES PANCREATIC ISLET PROLIFERATION AND INSULIN PRODUCTION IN EXPERIMENTALLY-INDUCED TYPE 2 DIABETES IN RATS

Role of Metformin in Oxaliplatin-induced Peripheral Neuropathy in Colorectal Cancer Patients: Thesis Abstract

IS APELIN A PROMISING TARGET IN DIABETES MELLITUS OF RATS: TYPE I VS. TYPE II?

STUDY OF CIRCULATING TUMOR NECROSIS FACTOR-ALPHA: RELEVANCE TO INSULIN- DEPENDENT AND NON INSULIN-DEPENDENT DIABETES MELLITUS